HHS
State labs and commercial companies see rising spinal muscular atrophy test volumes as screening programs launch in US states and European countries, among others.
High payment rates for tests for rare disorders in regions covered by two Medicare Administrative Contractors could spark debate about genetic testing fraud.
HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects
The funding is being provided to 10 groups through the LymeX Diagnostics Prize initiative, which was launched in late 2020 by theHHS- and Cohen Foundation-backed Lyme Innovation Accelerator.
DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument
The Italian firm said the Liaison NES will help improve access to testing for bacterial and viral diseases through an easy-to-use instrument running lower cost assays.
FDA Allowed Problematic COVID-19 Tests on the Market Due to Agency's EUA Approach, HHS OIG Finds
In a report released on Wednesday, the office critiqued the FDA's pandemic performance and recommended new approaches.